References
1. Eastell R., Brandi M.L., Costa A.G., D’Amour P., et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop [published correction appears in J Clin Endocrinol Metab. 2015 May;100(5):2137]. J Clin Endocrinol Metab. 2014; 99 (10): 3570–9. DOI: https://doi.org/10.1210/jc.2014-1414
2. Cope O. The study of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med. 1966; 274 (21): 1174–82. DOI: https://doi.org/10.1056/NEJM196605262742105
3. Press D.M., Siperstein A.E., Berber E., et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013; 154 (6): 1232–8. DOI: https://doi.org/10.1016/j.surg.2013.06.051
4. Rao S.D., Frame B., Miller M.J., Kleerekoper M., et al. Hyperparathyroidism following head and neck irradiation. Arch Intern Med. 1980; 140 (2): 205–7. DOI: https://doi.org/10.1001/archinte.1980.00330140063019
5. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [published correction appears in N Engl J Med. 2000; 342 (2): 144]. N Engl J Med. 1999; 341 (17): 1249–55. DOI: https://doi.org/10.1056/NEJM199910213411701
6. Brown E.M. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract Res Clin Endocrinol Metab. 2013; 27 (3): 333–43. DOI: https://doi.org/10.1016/j.beem.2013.02.006
7. Nesbit M.A., Hannan F.M., Howles S.A., et al. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med. 2013; 368 (26): 2476–86. DOI: https://doi.org/10.1056/NEJMoa1300253
8. Wilhelm S.M., Wang T.S., Ruan D.T., et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016; 151 (10): 959–68. DOI: https://doi.org/10.1001/jamasurg.2016.2310
9. Gribeler M.L., et al. Secular trends in the incidence of primary hyperparathyroidism over five decades. Bone. 2016; 73: 1–7.
10. Miller P.D., Bilezikian J.P. Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res. 2002; 17 (Suppl 2): 98–102.
11. Albright F., Aub J.C., Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA. 1934; 102: 1276–87.
12. Mokrysheva N.G., Eremkina A.K., Mirnaya S.S., Krupinova J.A., et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problemi Endocrinologii [Problems of Endocrinology]. 2021; 67 (4): 94–124. DOI: https://doi.org/10.14341/probl12801 (in Russian)
13. Naji Rad S., Deluxe L. Osteitis fibrosa cystica. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
14. Misiorowski W, Bilezikian JP. Osteitis Fibrosa Cystica. JBMR Plus. 2020; 4 (9): e10403. DOI: https://doi.org/10.1002/jbm4.10403